Latest News On Guns

Latest 蘑菇影院 Health News Stories

蘑菇影院 Health News' 'What the Health?': More Medicaid Messiness

Podcast

At least 30 states are reinstating coverage for children wrongly removed from the rolls under Medicaid redetermination, the federal government reported. It鈥檚 just the latest hiccup in the massive effort to review the eligibility of Medicaid beneficiaries now that the program鈥檚 pandemic-era expansion has expired. And federal oversight of the so-called unwinding would be further complicated by an impending government shutdown. Rachel Roubein of The Washington Post, Sandhya Raman of CQ Roll Call, and Sarah Karlin-Smith of Pink Sheet join 蘑菇影院 Health News chief Washington correspondent Julie Rovner to discuss these issues and more. Also this week, Rovner interviews 蘑菇影院 Health News鈥 Samantha Liss, who reported and wrote the latest 蘑菇影院 Health News-NPR 鈥淏ill of the Month鈥 feature, about a hospital bill that followed a deceased patient鈥檚 family for more than a year.

蘑菇影院 Health News' 'What the Health?': Abortion Pill鈥檚 Legal Limbo Continues

Podcast

A federal appeals court issued a split decision on whether the abortion pill mifepristone should remain on the market 鈥 rejecting a lower court鈥檚 decision to effectively cancel the drug鈥檚 FDA approval in 2000, while ordering the rollback of more recent rules that made the drug easier to obtain. Nothing changes immediately, however, as the Supreme Court blocked the lower court鈥檚 ruling in the spring. It will be up to the high court to determine whether the pill remains available in the U.S. and under which conditions. Sarah Karlin-Smith of the Pink Sheet, Alice Miranda Ollstein of Politico, and Shefali Luthra of The 19th join 蘑菇影院 Health News鈥 chief Washington correspondent, Julie Rovner, to discuss these issues and more. Plus, for 鈥渆xtra credit,鈥 the panelists suggest health policy stories they read this week they think you should read, too.

蘑菇影院 Health News' 'What the Health?': The Confusing Fate of the Abortion Pill

Podcast

The legality and availability of the abortion pill mifepristone is in question after a federal judge in Texas canceled the FDA鈥檚 approval of the first drug used in the two-drug medication abortion regimen. A 5th Circuit Court of Appeals panel overruled that decision in part, saying the pill should remain available, but only under the onerous restrictions in place before 2016. Meanwhile, another federal judge in Washington state issued a ruling in a separate case that conflicts with the Texas decision, ordering the FDA not to roll back any of its restrictions on the drug. Victoria Knight of Axios, Shefali Luthra of The 19th, and Sarah Karlin-Smith of the Pink Sheet join 蘑菇影院 Health News chief Washington correspondent Julie Rovner to discuss these issues and more.